ConductScience.org, home

Paper17522507

Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?

Clavien PA. Ann Surg, 2007. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection? Papers, record 17522507. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522507

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?
PubMed
Journal
Ann Surg
PubMed
Year
2007
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2018-12-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clavien PAPierre-A

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Carcinoma, HepatocellularMajor topic
Interferon-alphaMajor topic
Liver NeoplasmsMajor topic
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Hepatectomy
Hepatitis B
Humans
Interferon alpha-2
Liver Transplantation
Male
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Recombinant Proteins
Survival Rate
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01681446Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 ExpressionBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in18438131Re: Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?https://conductscience.org/library/papers/18438131PubMed
Comment on17522506A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.https://conductscience.org/library/papers/17522506PubMed

Download CSV of comments and corrections

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18594428Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996https://conductscience.org/library/papers/8594428PubMed
215048738Critical evaluation of the different staging systems for hepatocellular carcinoma.Br J Surg2004https://conductscience.org/library/papers/15048738PubMed
37881929Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal.Br J Surg1995https://conductscience.org/library/papers/7881929PubMed
48609071A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.Jpn J Cancer Res1996https://conductscience.org/library/papers/8609071PubMed
58628336Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group.N Engl J Med1996https://conductscience.org/library/papers/8628336PubMed
610459961Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.Lancet1999https://conductscience.org/library/papers/10459961PubMed
715785088Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.Intervirology2005https://conductscience.org/library/papers/15785088PubMed
815827439Surgical therapy of hepatocellular carcinoma.Eur J Gastroenterol Hepatol2005https://conductscience.org/library/papers/15827439PubMed
915918144Prevention of hepatocellular carcinoma.Semin Liver Dis2005https://conductscience.org/library/papers/15918144PubMed
1015921814Third forum on liver transplantation. Living donor liver transplantation. Who needs it? How to do it? Who should do it?J Hepatol2005https://conductscience.org/library/papers/15921814PubMed
1116112768Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.J Hepatol2005https://conductscience.org/library/papers/16112768PubMed
1216897271Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.Ann Surg Oncol2006https://conductscience.org/library/papers/16897271PubMed
1317133492Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.Hepatology2006https://conductscience.org/library/papers/17133492PubMed
1417429086Strategies for safer liver surgery and partial liver transplantation.N Engl J Med2007https://conductscience.org/library/papers/17429086PubMed
1517522506A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.Ann Surg2007https://conductscience.org/library/papers/17522506PubMed
1616557381Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.J Cancer Res Clin Oncol2006https://conductscience.org/library/papers/16557381PubMed
1710613728Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma.Hepatology2000https://conductscience.org/library/papers/10613728PubMed
1810915728Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer.Hepatology2000https://conductscience.org/library/papers/10915728PubMed
1911352697Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.Ann Intern Med2001https://conductscience.org/library/papers/11352697PubMed
2011668491Estimating the world cancer burden: Globocan 2000.Int J Cancer2001https://conductscience.org/library/papers/11668491PubMed

See all 26 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
39212922Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.Cancer Treat Res2024https://conductscience.org/library/papers/39212922PubMed
33527025IFN-α facilitates the effect of sorafenib via shifting the M2-like polarization of TAM in hepatocellular carcinoma.Am J Transl Res2021https://conductscience.org/library/papers/33527025PubMed
29358721Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma.Cell Death Dis2018https://conductscience.org/library/papers/29358721PubMed
26595239Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Immunology2016https://conductscience.org/library/papers/26595239PubMed
26584517Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells.Sci Rep2015https://conductscience.org/library/papers/26584517PubMed
25279210
Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis.
Mol Clin Oncol2014https://conductscience.org/library/papers/25279210PubMed
24696596Systemic therapy of hepatocellular carcinoma: current status and future perspectives.World J Gastroenterol2014https://conductscience.org/library/papers/24696596PubMed
23569435Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma.Int J Biol Sci2013https://conductscience.org/library/papers/23569435PubMed
23025904Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.BMC Cancer2012https://conductscience.org/library/papers/23025904PubMed
22752423Treatment Response After Unusual Low Dose Sorafenib: Diagnosis with Perfusion CT and Follow-up in a Patient with Recurrent Hepatocellular Carcinoma.J Gastrointest Cancer2012https://conductscience.org/library/papers/22752423PubMed
22056812Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1).Cancer Lett2012https://conductscience.org/library/papers/22056812PubMed
19812400MicroRNA expression, survival, and response to interferon in liver cancer.N Engl J Med2009https://conductscience.org/library/papers/19812400PubMed
19155200Surgical treatment for hepatocellular carcinoma in cirrhotic patients. Guide to the selection and decision-making process in a context of multimodal strategy.Clin Transl Oncol2009https://conductscience.org/library/papers/19155200PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17522507

GET https://conductscience.org/api/papers/v1/17522507/references?page=2